Interplay between HMGA and TP53 in cell cycle control along tumor progression

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Aberrant expression of High Mobility Group A (HMGA) proteins is observed in various tumors, with overexpression implicated in carcinogenesis.
• Tumor Protein p53 (TP53) is frequently altered in cancer; its loss of activity removes a critical barrier against neoplastic transformation.

Purpose of the Study:

• To review the interaction and opposing effects of HMGA and p53 proteins on cell cycle regulation in normal and tumor cells.
• To explore the potential of targeting HMGA and p53 in combination for cancer therapy.

Main Methods:

• Literature review focusing on in vitro and in vivo studies.
• Analysis of the regulatory mechanisms of HMGA and p53 on cell cycle progression.
• Discussion of the reciprocal regulation and functional crosstalk between HMGA and p53.

Main Results:

• HMGA proteins regulate cell cycle progression, influencing malignant transformation.
• TP53 signaling is crucial for cell cycle control, primarily inducing arrest to prevent DNA damage and genomic instability.
• HMGA and p53 may reciprocally regulate each other's expression or activity, counteracting their regulatory effects at different cell cycle stages.

Conclusions:

• A functional crosstalk exists between HMGA and p53 in cell cycle control.
• Targeting HMGA and p53 in combination with cell cycle-regulating therapies may improve cancer patient management and prognosis.